The cluster is routine in size relative to market cap and tied to option exercises/vesting. No bearish signal. Monitor for any 8-K filings or material events that could explain the timing, but the pattern is consistent with normal portfolio diversification.
CORT drugs
CORT drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 5 $72.62entry
- T+1 · 5mo ago +0.98%α +0.75% · $73.33
- T+5 · 5mo ago +14.17%α +13.60% · $82.91
- T+20 · 4mo ago +26.15%α +24.29% · $91.61
- T+60 · 3mo ago +56.09%α +52.09% · $113.35
Price Chart
How similar events traded
Executive Summary
Five Corcept Therapeutics insiders, including the CEO, CFO, and Chief Development Officer, sold a total of $6.91M in open-market shares over a 7-day window. The sales are clustered around the vesting and exercise of stock options and restricted stock units, suggesting a liquidity/planning motive rather than a coordinated bearish signal. The total value represents ~0.09% of the $7.8B market cap, which is below the 0.1% materiality threshold for insider sales.
Key Financial Metrics
Key Facts
- Total insider sales of $6.91M across 5 insiders in a 7-day window
- CEO Joseph Belanoff sold $895K, CFO Atabak Mokari sold $2.80M, CDO William Guyer sold $1.41M
- Sales coincide with option exercises and RSU vesting (non-cash grants of $0 exercise price)
- Total sales represent ~0.09% of Corcept's $7.8B market cap
- CEO also made a non-cash gift of 300,000 shares on May 29
Financial Impact
Total insider sales of $6.91M, or ~0.09% of market cap
Risk Factors
- Insider sales could accelerate if stock continues to rise
- CEO gift of 300K shares may precede further selling by donee
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-CORT-1780606298668 |
Track record
36 reports on CORT
8 of 9 bullish or bearish reports moved the stock their way by T+20. Best: +63.06% at T+60 after the Feb 24, 2026 report. 10 of 11 went positive at some point.
Filters
- Nov 13, 20263d ago Insider Cluster Neutral 2/10 Entry $73.87 Now $69.22 −6.29% settles Dec 15
- Nov 10, 20266d ago 144 Neutral 2/10 Entry $74.53 Now $69.22 −7.12% settles Dec 10
- Nov 4, 202612d ago Insider Cluster Neutral 2/10 Entry $71.63 Now $69.22 −3.36% settles Dec 4
- Nov 3, 202613d ago 8-K Bullish 6/10 Entry $79.22 Now $69.22 −12.62% settles Dec 3
- Nov 2, 202614d ago Institutional Cluster Bearish 4/10 Entry $81.93 Now $69.22 +15.51% settles Dec 2
- Oct 27, 202620d ago SC 13G/A Neutral 3/10 Entry $86.28 Now $69.22 −19.77% settles Nov 25
- Oct 5, 20266w ago Insider Cluster Neutral 3/10 Entry $119.57 to $81.93 Now $69.22 −42.11% ▼ −31.48% −28.30% vs SPY
- Sep 23, 20267w ago 8-K Neutral 3/10 Entry $112.94 to $116.28 Now $69.22 −38.71% ▲ +2.96% +2.27% vs SPY
- Sep 16, 20268w ago Insider Cluster Bearish 4/10 Entry $114.86 to $113.37 Now $69.22 +39.74% ▲ +1.30% +2.50% vs SPY
- Sep 16, 20268w ago Insider Cluster Bearish 4/10 Entry $114.86 to $113.37 Now $69.22 +39.74% ▲ +1.30% +2.75% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers